With 2026 on the horizon, pharma leaders are already looking ahead. European Pharmaceutical Manufacturer asked industry voices what they think 2026 will bring, from innovation and AI to regulation and resilience. Here’s what they had to say.
Ross Meyercord, CEO, Propel Software
Next year will mark the tipping point for connected intelligence. Software platforms that extend data and workflows across the enterprise will dominate, while isolated tools will fade into irrelevance. Agentic AI is already proving that productivity breakthroughs come from collaboration, between systems as much as people.